Shin Fujisawa

6PUBLICATIONS
23CO-AUTHORS
Molecular targetsNanomedicineHaematological tumoursPredictive and prognostic markersHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 11, 2026
Early predictors of MR4.5 attainment and eligibility for TKI discontinuation in CML treated with second-generation TKIs.

|Aug 02, 2025
The Impact of Tirabrutinib Monotherapy for the Treatment of Bing-Neel Syndrome: A Multicenter Retrospective Study.

Masuho Saburi, Taro Masunari, Noriko Fukuhara

|Jul 05, 2024
Nilotinib vs dasatinib in achieving MR4.5 for de novo chronic myeloid leukemia: the randomized JALSG CML212 study.

Itaru Matsumura, Shigeki Ohtake, Yoshiko Atsuta

|Feb 08, 2024
Differential clinical impact of letermovir prophylaxis according to graft sources: a KSGCT multicenter retrospective analysis.

Takashi Toya, Kota Mizuno, Masatoshi Sakurai

|Feb 05, 2024
Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission.

Satoshi Nishiwaki, Isamu Sugiura, Shin Fujisawa

|Jan 20, 2017
Phase II study of imatinib-based chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia.

Shin Fujisawa, Shuichi Mizuta, Hideki Akiyama

Pageof 1

Frequent Collaborators

3 joint publications

Itaru Matsumura

3 joint publications

Emiko Sakaida

2 joint publications

Naoto Takahashi

2 joint publications

Takaaki Ono